Skip to content

Physical Activity Program for Counteracting Sarcopenia

Effects of an Home-base Physical Activity Program for Counteracting Sarcopenia in Elderly: a Randomized-controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04172285
Acronym
EXERSARCO
Enrollment
16
Registered
2019-11-21
Start date
2019-09-18
Completion date
2021-12-20
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Brief summary

Sarcopenia is a pathophysiological process associated with aging and some metabolic conditions characterized by progressive muscle tissue loss, which may lead to loss of strangth and performance and increase risk of falls and fractures, physical disability and premature death. Therefore, it is necessary to identify personalized programs of physical activity and supplementation for elderly population in order to improve their physical functions, muscle strengh and body composition. With the present project we aime to assess the effect of a feasible home-based exercise program coupled with food supplementation to improve muscle strength, muscle volume and muscle physical performance potentially associated with sarcopenia in elderly people.

Interventions

BEHAVIORALPhysical activity

Home-based physical activity program

DIETARY_SUPPLEMENTPhysical activity and supplementation

Home-based physical activity program and amminoacid supplementation

OTHERControl

No intervention

Sponsors

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Sedentary lifestyle. * Cognitively intact. * Autonomous walking. * Acceptance of informed consent.

Exclusion criteria

* Body mass index lower than 18.5 and uppen than 40 kg/m2. * History of cancer. * Pacemaker user. * History of epileptic episodes. * Endocrine-metabolic, neurological, muscular and ortopedic pathologies that affect movement functions. * Bone fractures that influence movement functions. * Smoking. * Surgical treatments in the prior 6 months. * Use of antieptilectics, glucocorticoids, rhGH and testosterone. * Hepatic and muscular pathologies

Design outcomes

Primary

MeasureTime frameDescription
Lower limb strengthBaseline and Week 24Assessed by chair stand test

Secondary

MeasureTime frameDescription
Body compositionBaseline and Week 24Assessed by Whole-body dual energy X-ray absorptiometry
Quantify thigh cross sectional areaBaseline and Week 24Assessed by Dixon magnetic resonance imaging
Maximum isometric force that a hand can squeezeBaseline and Week 24Assessed by Hand Grip Strength test
Maximal Isometric Strength of Knee flexors and extensorsBaseline AND Week 24Assessed by a belt-stabilized dynamometer
Dynamic balance and gait deficitsBaseline and Week 24Assessed by mini-BESTest

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026